CoChat

Vascular Oxidative Stress: The Common Link in Hypertensive and Diabetic Vascular Disease

Open access
Cohen, Richard A, Tong, XiaoYong · 2010 · Journal of Cardiovascular Pharmacology
Cited by 125

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Vascular disease in hypertension and diabetes is associated with increased oxidants. The oxidants arise from NADPH oxidase, xanthine oxidase, and mitochondria. Superoxide anion and hydrogen peroxide are produced by both leukocytes and vascular cells. Nitric oxide is produced in excess by inducible nitric oxide synthase, and the potent oxidant, peroxynitrite, is formed from superoxide and nitric oxide. The damage to proteins caused by oxidants is selective, affecting specific oxidant-sensitive amino acid residues. With some important vascular proteins, for example, endothelial nitric oxide synthase, prostacycline synthase, and superoxide dismutase, oxidation of a single susceptible amino acid inactivates the enzyme. The beneficial effects of antioxidants, at least in animal models of hypertension and diabetes, can in part be ascribed to protection of these and other proteins. Mutant proteins lacking their reactive constituent can recapitulate some disease phenotypes suggesting a pathogenic role of the oxidation. Thus, many of the shared functional abnormalities of hypertensive and diabetic blood vessels may be caused by oxidants. Although studies using antioxidants have failed in patients, the successful treatment of vascular disease with HMG-CoA reductase inhibitors, thromboxane A2 antagonists, and polyphenols may depend on their anti-inflammatory effects and ability to decrease production of damaging oxidants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/fjc.0b013e3181d89670

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 77

  1. Contreras, 2000, J Hum Hypertens, 14, S26, 10.1038/sj.jhh.1000983 · DOI
  2. Savoia, 2006, Curr Diab Rep, 6, 274, 10.1007/s11892-006-0060-5 · DOI
  3. Adachi, 2005, Drug Discov Today, 2, 39, 10.1016/j.ddmec.2005.05.022 · DOI
  4. Adachi, 2004, J Biol Chem, 279, 29857, 10.1074/jbc.M313320200 · DOI · Paper page
  5. Clavreul, 2006, FASEB J, 20, 518, 10.1096/fj.05-4875fje · DOI · Paper page
  6. Adachi, 2004, Nat Med, 10, 1200, 10.1038/nm1119 · DOI · Paper page
  7. Ying, 2007, Arterioscler Thromb Vasc Biol, 27, 783, 10.1161/01.ATV.0000258413.72747.23 · DOI · Paper page
  8. Meng, 2008, Cardiovasc Res, 80, 299, 10.1093/cvr/cvn173 · DOI · Paper page
  9. Touyz, 2004, Histochem Cell Biol, 122, 339, 10.1007/s00418-004-0696-7 · DOI · Paper page
  10. Touyz, 2003, Curr Opin Nephrol Hypertens, 12, 165, 10.1097/00041552-200303000-00007 · DOI
  11. Schiffrin, 2004, Am J Physiol Heart Circ Physiol, 287, H435, 10.1152/ajpheart.00262.2004 · DOI · Paper page
  12. Lassegue, 2003, Am J Physiol Regul Integr Comp Physiol, 285, R277, 10.1152/ajpregu.00758.2002 · DOI · Paper page
  13. Pagano, 1995, Am J Physiol, 268, H2274
  14. Wang, 1998, Circ Res, 82, 810, 10.1161/01.RES.82.7.810 · DOI · Paper page
  15. Wang, 1999, Hypertension, 33, 1225, 10.1161/01.HYP.33.5.1225 · DOI · Paper page
  16. Seshiah, 2002, Circ Res, 91, 406, 10.1161/01.RES.0000033523.08033.16 · DOI · Paper page
  17. Rajagopalan, 1996, J Clin Invest, 97, 1916, 10.1172/JCI118623 · DOI · Paper page
  18. Privratsky, 2003, Hypertension, 42, 206, 10.1161/01.HYP.0000082814.62655.85 · DOI · Paper page
  19. Ghiadoni, 2003, Hypertension, 41, 1281, 10.1161/01.HYP.0000070956.57418.22 · DOI · Paper page
  20. Wang, 2001, Circ Res, 88, 947, 10.1161/hh0901.089987 · DOI · Paper page
  21. Jung, 2004, Circulation, 109, 1795, 10.1161/01.CIR.0000124223.00113.A4 · DOI · Paper page
  22. Zhou, 2006, Hypertension, 47, 81, 10.1161/01.HYP.0000197182.65554.c7 · DOI
  23. Haurani, 2007, Cardiovasc Res, 75, 679, 10.1016/j.cardiores.2007.06.016 · DOI · Paper page
  24. Landmesser, 2002, Hypertension, 40, 511, 10.1161/01.HYP.0000032100.23772.98 · DOI · Paper page
  25. Williams, 1998, Circulation, 97, 1695, 10.1161/01.CIR.97.17.1695 · DOI · Paper page
  26. Rask-Madsen, 2007, Nat Clin Pract Endocrinol Metab, 3, 46, 10.1038/ncpendmet0366 · DOI · Paper page
  27. Liu, 2007, Free Radic Biol Med, 42, 852, 10.1016/j.freeradbiomed.2006.12.025 · DOI
  28. Guzik, 2002, Circulation, 105, 1656, 10.1161/01.CIR.0000012748.58444.08 · DOI · Paper page
  29. Lopez-Lopez, 2008, Am J Physiol Lung Cell Mol Physiol, 295, L727, 10.1152/ajplung.90354.2008 · DOI
  30. Ulker, 2004, Diabetes Obes Metab, 6, 442, 10.1111/j.1462-8902.2004.00443.x · DOI
  31. Vecchione, 2006, Circ Res, 98, 218, 10.1161/01.RES.0000200440.18768.30 · DOI
  32. Wei, 2007, Hypertension, 50, 384, 10.1161/HYPERTENSIONAHA.107.089284 · DOI · Paper page
  33. Molnar, 2005, Circ Res, 96, 1178, 10.1161/01.RES.0000168634.74330.ed · DOI · Paper page
  34. Matsumoto, 2003, Free Radic Res, 37, 767, 10.1080/1071576031000107344 · DOI · Paper page
  35. Cohen, 1993, Circulation, 87, V67
  36. Yang, 2002, Br J Pharmacol, 136, 104, 10.1038/sj.bjp.0704669 · DOI · Paper page
  37. Yang, 2003, Hypertension, 41, 143, 10.1161/01.HYP.0000047651.45322.16 · DOI · Paper page
  38. Yang, 2004, Fundam Clin Pharmacol, 18, 321, 10.1111/j.1472-8206.2004.00247.x · DOI
  39. Kanie, 2000, General Pharmacology: The Vascular System, 35, 311, 10.1016/S0306-3623(02)00115-5 · DOI
  40. Luscher, 1986, Hypertension, 8, 344, 10.1161/01.HYP.8.4.344 · DOI · Paper page
  41. Luscher, 1988, Hypertension, 11, 573, 10.1161/01.HYP.11.6.573 · DOI
  42. Diederich, 1990, Am J Physiol, 258, H445
  43. Bayat, 2008, Arterioscler Thromb Vasc Biol, 28, 127, 10.1161/ATVBAHA.107.150250 · DOI
  44. Zuccollo, 2005, Circulation, 112, 3001, 10.1161/CIRCULATIONAHA.105.581892 · DOI
  45. Xu, 2006, Diabetes, 55, 110, 10.2337/diabetes.55.01.06.db05-0831 · DOI · Paper page
  46. Wassmann, 2004, Hypertension, 44, 381, 10.1161/01.HYP.0000142232.29764.a7 · DOI · Paper page
  47. Redon, 2003, Hypertension, 41, 1096, 10.1161/01.HYP.0000068370.21009.38 · DOI · Paper page
  48. Tanito, 2004, Antioxid Redox Signal, 6, 89, 10.1089/152308604771978381 · DOI · Paper page
  49. Tagami, 1992, Metabolism, 41, 1053, 10.1016/0026-0495(92)90285-I · DOI
  50. Scheede-Bergdahl, 2005, Diabetes, 54, 3089, 10.2337/diabetes.54.11.3089 · DOI
  51. Zou, 1999, Am J Pathol, 154, 1359, 10.1016/S0002-9440(10)65390-4 · DOI · Paper page
  52. Schmidt, 2003, J Biol Chem, 278, 12813, 10.1074/jbc.M208080200 · DOI · Paper page
  53. Zou, 2002, Diabetes, 51, 198, 10.2337/diabetes.51.1.198 · DOI · Paper page
  54. Guo, 2003, Am J Physiol Heart Circ Physiol, 285, H1396, 10.1152/ajpheart.00096.2003 · DOI · Paper page
  55. Rosenthal, 2009, Journal of Biological Inorganic Chemistry, 14, 979, 10.1007/s00775-009-0550-4 · DOI
  56. Ying, 2008, Free Radic Biol Med, 45, 756, 10.1016/j.freeradbiomed.2008.05.029 · DOI
  57. Adachi, 2002, Circ Res, 90, 1114, 10.1161/01.RES.0000019757.57344.D5 · DOI · Paper page
  58. Beswick, 2001, Hypertension, 37, 781, 10.1161/01.HYP.37.2.781 · DOI · Paper page
  59. Hoffmann, 2008, Hypertension, 51, 1058, 10.1161/HYPERTENSIONAHA.107.107219 · DOI
  60. Jagadeesha, 2005, Am J Physiol Heart Circ Physiol, 289, H1047, 10.1152/ajpheart.01071.2004 · DOI
  61. Trujillo, 2008, Am J Physiol Renal Physiol, 295, F1574, 10.1152/ajprenal.90385.2008 · DOI
  62. DeRubertis, 2004, Diabetes, 53, 762, 10.2337/diabetes.53.3.762 · DOI · Paper page
  63. Ting, 1996, J Clin Invest, 97, 22, 10.1172/JCI118394 · DOI · Paper page
  64. Ting, 1996, Circulation, 94, I
  65. Plotnick, 1997, JAMA, 278, 1682, 10.1001/jama.1997.03550200058032 · DOI · Paper page
  66. Farmer, 2003, Am J Cardiol, 92, 3, 10.1016/S0002-9149(03)00503-4 · DOI
  67. Keli, 1996, Arch Intern Med, 154, 637, 10.1001/archinte.1996.00440060059007 · DOI · Paper page
  68. Leng, 1997, Vascular Medicine, 2, 279, 10.1177/1358863X9700200401 · DOI
  69. de Aguiar, 2006, Diabetes Care, 29, 1083, 10.2337/dc05-2146 · DOI · Paper page
  70. Rueckschloss, 2001, Circulation, 104, 1767, 10.1161/hc4001.097056 · DOI · Paper page
  71. Sumi, 2001, Atherosclerosis, 155, 347, 10.1016/S0021-9150(00)00597-9 · DOI
  72. Wagner, 2002, Arterioscler Thromb Vasc Biol, 20, 61, 10.1161/01.ATV.20.1.61 · DOI · Paper page
  73. Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
  74. Virdis, 2009, Hypertension, 53, 1008, 10.1161/HYPERTENSIONAHA.109.132258 · DOI
  75. Cayatte, 2000, Arterioscler Thromb Vasc Biol, 20, 1724, 10.1161/01.ATV.20.7.1724 · DOI · Paper page
  76. Zang, 2006, Diabetes, 55, 2180, 10.2337/db05-1188 · DOI · Paper page
  77. Cayatte, 2001, Arterioscler Thromb Vasc Biol, 21, 1577, 10.1161/hq1001.096723 · DOI · Paper page

Cited by

Metadata

Authors
Cohen, R. A., & Tong, X.
Venue
Journal of Cardiovascular Pharmacology
Published
2010-04
Volume
55
Issue
4
Pages
308-316
ISSN
0160-2446 (ISSN-L)
OpenAlex
W2005457857
Cited by
125
References
25
FWCI
8.94
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.